[DPHARMA] YoY TTM Result on 31-Mar-2015 [#1]

Stock
[DPHARMA] DUOPHARMA BIOTECH BERHAD
Announcement Date
18-May-2015
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2015
Quarter
31-Mar-2015 [#1]
Profit Trend
QoQ- 1.69%
YoY- 3.21%
Quarter Report
Latest QR
Upcoming QR
DPHARMA's Result
DPHARMA's Financial Summary
View:
Show?
TTM Result
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Revenue 477,940 354,464 304,911 182,065 165,062 137,091 141,205 22.52%
PBT 52,929 32,714 47,508 47,513 42,396 35,384 35,723 6.76%
Tax -9,746 -5,098 -9,864 -8,428 -7,243 -9,378 -8,233 2.85%
NP 43,183 27,616 37,644 39,085 35,153 26,006 27,490 7.81%
-
NP to SH 43,710 27,890 37,659 36,283 35,153 26,006 27,490 8.03%
-
Tax Rate 18.41% 15.58% 20.76% 17.74% 17.08% 26.50% 23.05% -
Total Cost 434,757 326,848 267,267 142,980 129,909 111,085 113,715 25.03%
-
Net Worth 206,429 463,071 457,740 205,045 190,050 176,143 170,824 3.20%
Dividend
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Div 23,711 19,142 5,682 25,682 24,289 19,431 24,987 -0.86%
Div Payout % 54.25% 68.64% 15.09% 70.79% 69.10% 74.72% 90.90% -
Equity
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Net Worth 206,429 463,071 457,740 205,045 190,050 176,143 170,824 3.20%
NOSH 278,959 278,959 278,959 139,486 138,723 138,695 138,881 12.32%
Ratio Analysis
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
NP Margin 9.04% 7.79% 12.35% 21.47% 21.30% 18.97% 19.47% -
ROE 21.17% 6.02% 8.23% 17.70% 18.50% 14.76% 16.09% -
Per Share
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 171.33 127.07 109.24 130.52 118.99 98.84 101.67 9.08%
EPS 15.67 10.00 13.49 26.01 25.34 18.75 19.79 -3.81%
DPS 8.50 6.86 2.04 18.50 17.50 14.00 18.00 -11.74%
NAPS 0.74 1.66 1.64 1.47 1.37 1.27 1.23 -8.11%
Adjusted Per Share Value based on latest NOSH - 139,486
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
RPS 49.68 36.85 31.70 18.93 17.16 14.25 14.68 22.51%
EPS 4.54 2.90 3.91 3.77 3.65 2.70 2.86 8.00%
DPS 2.46 1.99 0.59 2.67 2.53 2.02 2.60 -0.91%
NAPS 0.2146 0.4814 0.4759 0.2132 0.1976 0.1831 0.1776 3.20%
Price Multiplier on Financial Quarter End Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 30/03/18 31/03/17 31/03/16 31/03/15 31/03/14 29/03/13 30/03/12 -
Price 2.80 2.31 2.55 3.88 3.03 2.23 2.40 -
P/RPS 1.63 1.82 2.33 2.97 2.55 2.26 2.36 -5.97%
P/EPS 17.87 23.10 18.90 14.92 11.96 11.89 12.13 6.66%
EY 5.60 4.33 5.29 6.70 8.36 8.41 8.25 -6.25%
DY 3.04 2.97 0.80 4.77 5.78 6.28 7.50 -13.96%
P/NAPS 3.78 1.39 1.55 2.64 2.21 1.76 1.95 11.65%
Price Multiplier on Announcement Date
31/03/18 31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 CAGR
Date 28/05/18 22/05/17 18/05/16 18/05/15 20/05/14 27/05/13 17/05/12 -
Price 3.35 2.32 2.40 3.90 3.09 2.51 2.38 -
P/RPS 1.96 1.83 2.20 2.99 2.60 2.54 2.34 -2.90%
P/EPS 21.38 23.20 17.79 14.99 12.19 13.39 12.02 10.06%
EY 4.68 4.31 5.62 6.67 8.20 7.47 8.32 -9.13%
DY 2.54 2.96 0.85 4.74 5.66 5.58 7.56 -16.61%
P/NAPS 4.53 1.40 1.46 2.65 2.26 1.98 1.93 15.27%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment